Clinical Trials Directory

Trials / Sponsors / Altor BioScience

Altor BioScience

Industry · 15 registered clinical trials.

StatusTrialPhaseStarted
TerminatedPK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)
Pharmacokinetics
—2019-12-09
CompletedQUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803
Healthy
Phase 12017-12-27
CompletedQUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Pacli
Advanced Pancreatic Cancer
Phase 12016-07-01
TerminatedQUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab
Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma
Phase 1 / Phase 22015-04-17
TerminatedQUILT-3.005: A Study of N-803 in Patients With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Phase 12014-10-06
CompletedA Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Phase 12014-05-01
TerminatedQUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Phase 1 / Phase 22012-08-14
TerminatedA Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer
Phase 1 / Phase 22012-03-30
WithdrawnALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia
Acute Myeloid Leukemia
Phase 12011-11-01
CompletedA Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial C
Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer
Phase 1 / Phase 22011-09-06
CompletedA Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Locally Advanced Malignant Neoplasm, Malignant Solid Tumour
Phase 12011-05-01
CompletedQUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma
Metastatic Melanoma
Phase 1 / Phase 22010-02-01
CompletedAnti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndr
Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
Phase 22009-04-01
CompletedSafety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies
Progressive Metastatic Malignancies
Phase 12007-05-01
CompletedEffects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome
Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
Phase 12004-12-01